|
|
|
| Liver transplantation for patients with intrahepatic cholangiocarcinoma |
| Adarsh Vijay ∗, Hoonbae Jeon |
Division of Hepato-Pancreato-Biliary & Abdominal Transplant Surgery; Tulane Abdominal Transplant Institute, Tulane University School of Medicine, New
Orleans, LA 70112-2632, USA
∗ Corresponding author.
E-mail address: avijay@tulane.edu (A. Vijay).
|
|
|
|
|
Abstract Cholangiocarcinoma (CCA) constitutes a group of heterogeneous malignant tumors emerging in the biliary tree [1]. Based on their anatomical distribution, CCA is classified into perihilar cholangiocarcinoma (pCCA), distal cholangiocarcinoma (dCCA) and intrahepatic cholangiocarcinoma (iCCA) and they account for 60%-70%, 20%-30% and 5%-10% of CCA, respectively. The past decade has seen a 2-fold increase in annual percentage change in incidence of iCCA in USA when compared to the prior three decades [2].
|
|
|
|
|
|
|
|
|
2022, Vol. 21 
